Clinical applications of mesenchymal stem cells in laryngotracheal reconstruction

Current Stem Cell Research and Therapy

Volumn 5, Issue 3, 2010, Pages 268-272

  Hanson, Summer E ^a   Thibeault, Susan L ^a,b   Hematti, Peiman ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Human vocal fold stem cells; Immune modulation; Laryngotracheal reconstruction; Mesenchymal stem cells

Indexed keywords

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL THERAPY; GLOTTIS; IMMUNOMODULATION; LARYNGOPLASTY; MESENCHYME CELL; PRIORITY JOURNAL; STEM CELL; TRACHEA RECONSTRUCTION; VOCAL CORD; CYTOLOGY; HUMAN; LARYNX DISORDER; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; PLASTIC SURGERY; REVIEW; TISSUE ENGINEERING; TRACHEA DISEASE;

HUMANS; LARYNGEAL DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RECONSTRUCTIVE SURGICAL PROCEDURES; TISSUE ENGINEERING; TRACHEAL DISEASES;

EID: 77957667005     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488810791824449     Document Type: Article

References (70)

1. Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med 2008; 3(1): 1-5.
2. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007; 211(1): 27-35.
3. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7(2): 211-228.
4. Beahm EK, Walton RL, Patrick CW, Jr. Progress in adipose tissue construct development. Clin Plast Surg 2003; 30(4): 547-558, viii.
5. Van RL, Bayliss CE, Roncari DA. Cytological and enzymological characterization of adult human adipocyte precursors in culture. J Clin Invest 1976; 58(3): 699-704.
6. Trivedi P, Hematti P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol 2008; 36(3): 350-359.
7. Hematti P. Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) 2008; 22(4): 262-273.
8. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9(5): 641-650.
9. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119(Pt 11): 2204-2213.
10. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213(2): 341-347.
11. Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 2007; 28(5): 219-226.
12. Noel D, Caton D, Roche S, et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 2008; 314(7): 1575-1584.
13. Prockop DJ. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther 2009; 17(6): 939-946.
14. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315-317.
15. Hanson SE, Kim J, Quinchia-Johnson BH, et al. Characterization of human mesenchymal stem cells from vocal fold fibroblasts. Laryngoscope 2010; 120: 546-551.
16. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells 2007; 25(11): 2896-2902.
17. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25(11): 2739-2749.
18. Dazzi F, Horwood NJ. Potential of mesenchymal stem cell therapy. Curr Opin Oncol 2007; 19(6): 650-655.
19. Falanga V, Iwamoto S, Chartier M, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007; 13(6): 1299-1312.
20. Yoshikawa T, Mitsuno H, Nonaka I, et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 2008; 121(3): 860-877.
21. Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapy for non-healing cutaneous wounds. Plast Reconstr Surg 2010; 125(2): 510-516.
22. Lataillade JJ, Doucet C, Bey E, et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2007; 2(5): 785-794.
23. Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005; 48(7): 1416-1423.
24. Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded adiposederived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009; 52(1): 79-86.
25. Yoshimura K, Sato K, Aoi N, et al. Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived. Stem Cells Dermatol Surg 2008; 34: 1178-1185.
26. Le Blanc K, Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007; 262(5): 509-525.
27. Le Blanc K, Samuelsson H, Gustafsson B, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007; 21(8): 1733-1738.
28. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110(10): 3499-3506.
29. Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129(1):118-129.
30. Tholpady SS, Ogle RC, Katz AJ. Adipose stem cells and solid organ transplantation. Curr Opin Organ Transplant 2009; 14(1): 51-55.
31. Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 2009; 11(5): 503-515.
32. American Society of Plastic Surgeons. 2006 National Plastic Surgery Statistics. 2006; Available at: www.plasticsurgery.org/media/statistics.
33. Titze IR. The physics of small-amplitude oscillation of the vocal folds. J Acoust Soc Am 1988; 83(4): 1536-52.
34. Gray SD. Cellular physiology of the vocal folds. Otolaryngol Clin North Am 2000; 33(4): 679-698.
35. Duflo S, Thibeault SL, Li W, Shu XZ, Prestwich G. Effect of a synthetic extracellular matrix on vocal fold lamina propria gene expression in early wound healing. Tissue Eng 2006; 12(11): 3201-3207.
36. Duflo S, Thibeault SL, Li W, Shu XZ, Prestwich GD. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng 2006; 12(8): 2171-2180.
37. Hansen JK, Thibeault SL. Current understanding and review of the literature: vocal fold scarring. J Voice 2006; 20(1):110-120.
38. Kluyskens P, Ringoir S. Follow-up of a human larynx transplantation. Laryngoscope 1970; 80(8): 1244-1250.
39. Strome M, Stein J, Esclamado R, et al. Laryngeal transplantation and 40-month follow-up. N Engl J Med 2001; 344(22): 1676-1679.
40. Duque E, Duque J, Nieves M, Mejia G, Lopez B, Tintinago L. Management of larynx and trachea donors. Transplant Proc 2007; 39(7): 2076-2078.
41. Birchall M. Human laryngeal allograft: shift of emphasis in transplantation. Lancet 1998; 351(9102): 539-540.
42. Macchiarini P, Walles T, Biancosino C, Mertsching H. First human transplantation of a bioengineered airway tissue. J Thorac Cardiovasc Surg 2004; 128(4): 638-641.
43. Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008; 372(9655): 2023-30.
44. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367(9518): 1241-1246.
45. Pham C, Greenwood J, Cleland H, Woodruff P, Maddern G. Bioengineered skin substitutes for the management of burns: a systematic review. Burns 2007; 33(8): 946-957.
46. Woo P, Casper J, Colton R, Brewer D. Diagnosis and treatment of persistent dysphonia after laryngeal surgery: a retrospective analysis of 62 patients. Laryngoscope 1994; 104(9):1084-1091.
47. O'Leary MA, Grillone GA. Injection laryngoplasty. Otolaryngol Clin North Am 2006; 39(1): 43-54.
48. Kwon TK, Buckmire R. Injection laryngoplasty for management of unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg 2004; 12(6): 538-542.
49. Rosen CA, Thekdi AA. Vocal fold augmentation with injectable calcium hydroxylapatite: short-term results. J Voice 2004; 18(3): 387-391.
50. Hirano S, Bless DM, Heisey D, Ford CN. Effect of growth factors on hyaluronan production by canine vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2003; 112(7): 617-624.
51. Karpenko AN, Dworkin JP, Meleca RJ, Stachler RJ. Cymetra injection for unilateral vocal fold paralysis. Ann Otol Rhinol Laryngol 2003; 112(11): 927-934.
52. Lundy DS, Casiano RR, McClinton ME, Xue JW. Early results of transcutaneous injection laryngoplasty with micronized acellular dermis versus type-I thyroplasty for glottic incompetence dysphonia due to unilateral vocal fold paralysis. J Voice 2003; 17(4): 589-595.
53. Glatz FR, Kalkanis J, Neumeister M, Suchy H, Lyons S, Mowlavi A. Volume analysis of preadipocyte injection for vocal cord medialization. Laryngoscope 2003; 113(7): 1113-1117.
54. Laccourreye O, Papon JF, Kania R, Crevier-Buchman L, Brasnu D, Hans S. Intracordal injection of autologous fat in patients with unilateral laryngeal nerve paralysis: long-term results from the patient's perspective. Laryngoscope 2003; 113(3): 541-545.
55. Rihkanen H. Vocal fold augmentation by injection of autologous fascia. Laryngoscope 1998; 108(1 Pt 1): 51-54.
56. Moseley TA, Zhu M, Hedrick MH. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 2006; 118(3 Suppl): 121S-128S.
57. Lo Cicero V, Montelatici E, Cantarella G, et al. Do mesenchymal stem cells play a role in vocal fold fat graft survival? Cell Prolif 2008; 41(3): 460-473.
58. Mikaelian DO, Lowry LD, Sataloff RT. Lipoinjection for unilateral vocal cord paralysis. Laryngoscope 1991; 101(5): 465-468.
59. Shindo ML, Zaretsky LS, Rice DH. Autologous fat injection for unilateral vocal fold paralysis. Ann Otol Rhinol Laryngol 1996; 105(8): 602-606.
60. Dursun G, Boynukalin S, Ozgursoy OB, Coruh I. Long-term results of different treatment modalities for glottic insufficiency. Am J Otolaryngol 2008; 29(1): 7-12.
61. Hsiung MW, Woo P, Minasian A, Schaefer Mojica J. Fat augmentation for glottic insufficiency. Laryngoscope 2000; 110(6): 1026-1033.
62. Kanemaru S, Nakamura T, Omori K, et al. Regeneration of the vocal fold using autologous mesenchymal stem cells. Ann Otol Rhinol Laryngol 2003; 112(11): 915-920.
63. Kanemaru S, Nakamura T, Yamashita M, et al. Destiny of autologous bone marrow-derived stromal cells implanted in the vocal fold. Ann Otol Rhinol Laryngol 2005; 114(12): 907-912.
64. Hertegard S, Cedervall J, Svensson B, et al. Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection. Laryngoscope 2006; 116(7): 1248-1254.
65. Thibeault SL, Klemuk SA, Smith ME, Leugers C, Prestwich G. In vivo comparison of biomimetic approaches for tissue regeneration of the scarred vocal fold. Tissue Eng Part A 2009; 15(7): 1481-1487.
66. Quinchia-Johnson BH, Fox R, Chen X, Thibeault SL. Tissue regeneration of the vocal fold using bone marrow mesenchymal stem cells and synthetic extracellular matrix injections in rats. Laryngoscope In Review.
67. Allison M. Genzyme backs Osiris, despite Prochymal flop. Nat Biotechnol 2009; 27(11): 966-967.
68. Laurila JP, Laatikainen L, Castellone MD, et al. Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy 2009; 11(6): 726-737.
69. Kidd S, Spaeth E, Klopp A, Andreeff M, Hall B, Marini FC. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 2008; 10(7): 657-667.
70. Mishra PJ, Mishra PJ, Glod JW, Banerjee D. Mesenchymal stem cells: flip side of the coin. Cancer Res 2009; 69(4): 1255-1258.